These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18505086)

  • 1. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
    Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
    Anticancer Res; 2008; 28(2B):1399-404. PubMed ID: 18505086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
    Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma.
    Zhang L; Yuan SZ
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):620-3. PubMed ID: 14607699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma.
    Pryczynicz A; Guzińska-Ustymowicz K; Czyzewska J; Kemona A
    Folia Histochem Cytobiol; 2009; 47(4):667-71. PubMed ID: 20430737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between c-erbB-2 oncoprotein, epidermal growth factor receptor, and estrogen receptor expression in patients with ductal breast carcinoma. Association with tumor phenotypes.
    Harłoziñska A; Bar JK; Wenderski R; Bebenek M
    In Vivo; 1996; 10(2):217-22. PubMed ID: 8744803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
    Do NY; Lim SC; Im TS
    Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer.
    Dong M; Nio Y; Guo KJ; Tamura K; Tian YL; Dong YT
    Anticancer Res; 1998; 18(6B):4613-9. PubMed ID: 9891528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.
    Vaidya P; Kawarada Y; Higashiguchi T; Yoshida T; Sakakura T; Yatani R
    J Pathol; 1996 Feb; 178(2):140-5. PubMed ID: 8683379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.
    Ray A; Naik SL; Sharma BK
    Indian J Physiol Pharmacol; 2002 Oct; 46(4):423-33. PubMed ID: 12683217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
    Wei Q; Sheng L; Shui Y; Hu Q; Nordgren H; Carlsson J
    Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
    Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
    Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
    Kimura M; Tsuda H; Morita D; Shinto E; Tanimoto T; Ichikura T; Mochizuki H; Matsubara O
    Jpn J Clin Oncol; 2005 Jun; 35(6):324-31. PubMed ID: 15928192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
    Czyzewska J; Guzinska-Ustymowicz K; Kemona A
    Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays.
    Tsiambas E; Karameris A; Lazaris AC; Talieri M; Triantafillidis JK; Cheracakis P; Manaios L; Gerontopoulos K; Patsouris E; Lygidakis NJ
    Hepatogastroenterology; 2006; 53(69):452-7. PubMed ID: 16795991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.
    Lacroix H; Iglehart JD; Skinner MA; Kraus MH
    Oncogene; 1989 Feb; 4(2):145-51. PubMed ID: 2564657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection and expressions of EGF, EGFR and c-erbB-2 proteins in gastric carcinoma.
    Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
    Folia Histochem Cytobiol; 2009 Jan; 47(3):447-51. PubMed ID: 20164030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
    Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L
    Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions.
    Meert AP; Martin B; Verdebout JM; Feoli F; Mascaux C; Ninane V; Sculier JP
    Anticancer Res; 2006; 26(1A):135-8. PubMed ID: 16475689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.
    Xia W; Lau YK; Zhang HZ; Xiao FY; Johnston DA; Liu AR; Li L; Katz RL; Hung MC
    Clin Cancer Res; 1999 Dec; 5(12):4164-74. PubMed ID: 10632356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.